Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 mass balance and pharmacokinetic study of radiolabeled S44819 in healthy male volunteers
NL-OMON44446Phase 1Active, not recruiting
- Sponsor
- Servier
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of S44819 in ischemic stroke, sponsored by Servier. Primary endpoint: Excretion balance of total radioactivity in urine and faeces. Started Jul 2017; status: active, not recruiting.
02
Drugs
S44819
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NL-OMON44446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44446.